Elise M Garton, Gavin Allman, Hyo Sook Bae, Kalina Duncan, Ibithal Fadhil, Nazik Hammad, Shirin Heidari, Meritxell Mallafré-Larrosa, Jennifer Moodley, Rachel Nugent, Isabelle Soerjomataram, Carolyn D Taylor, Karla Unger-Saldaña, Verna Vanderpuye, Ophira Ginsburg.
The Lancet – April 15, 2025
The Lancet Commission on women, power, and cancer,1 hereafter referred to as the Commission, was created to address urgent questions at the intersection of social inequality, cancer risk and outcomes, and the status of women in society. Cancer is an increasingly important public health threat and economic challenge to all people worldwide, but has a disproportionate impact on the lives and livelihoods of women, which creates downstream impacts for society. The Commission applied an intersectional feminist lens2 to inform a nuanced, evidence-based, gendered approach to cancer risk and cancer control in response to this threat. The Commission report was published in September, 2023, with ten key findings and corresponding priority recommendations directed at a broad range of stakeholder communities: international organisations, national and subnational governments, researchers and research funders, civil society, and the private sector.1 To increase the likelihood that the recommendations set out in the Commission will be adopted and operationalised by multiple stakeholders, and to support the uptake of these recommendations, the authors proposed a framework and set of key performance indicators to guide implementation and to increase engagement of the global community at the nexus of gender, power, and cancer.